Clinical Trials Logo

Clinical Trial Summary

The objective of this post-market clinical follow-up study is to collect medical information on patients implanted with PuraStat®, according to each participating institution's procedures and standards of care.


Clinical Trial Description

This multicentre, single arm post-market clinical study aims to collect medical information on patients implanted with PuraStat®, Absorbable Haemostatic Material, according to each participating institution's procedures and standards of care for confirming the safety and the performance of PuraStat®, for the management of bleeding in vascular surgery (Carotid Endarterectomy either by direct closure (without the use of patch), or by patch reconstruction or eversion technique). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03103282
Study type Observational
Source 3-D Matrix Europe SAS
Contact
Status Completed
Phase
Start date June 14, 2017
Completion date August 30, 2019